Our Mission

To reduce cancer burden through innovative, epidemiologic research.

Research Projects

Determinants of cancer stage at diagnosis

Dr. Kopciuk

This project will explore factors associated with early stage of cancer at diagnosis, using data from Alberta’s Tomorrow Project The specific aims are to: (1) develop multivariable regression models using ordinal logistic regression to identify independent and synergistic factors (clinical, lifestyle, screening, etc.) associated with cancer stage at diagnosis; (2) develop spatial regression models to account for geographic and other factors …

The Breast Cancer and Exercise Trial in Alberta (BETA Trial)

Dr Friedenreich

The Breast Cancer and Exercise Trial in Alberta (BETA) is a randomized controlled exercise intervention trial. Dr. Friedenreich and her colleagues recruited 400 postmenopausal women aged 50-74 years of age to examine how a one-year high volume (300 minutes per week) versus moderate volume (150 minutes per week) aerobic exercise intervention influences and modifies biomarkers for breast cancer risk …

Breast Cancer to Bone (B2B) Metastases Research Program

Dr. Kopciuk and Dr. Friedenreich

The B2B research program established a cohort newly diagnosed breast cancer cases with the objective of studying how breast cancer metastasizes to the bone. This cohort study has involved several sub-projects including one currently led by Dr. Kopciuk to investigate the impact of vitamin D and markers of inflammation in breast cancer metastases. Other projects…

The Department of Cancer Epidemiology and Prevention Research

Since 2001, the scientists of CEPR have been combining traditional epidemiologic study designs with a molecular epidemiologic emphasis. The collection of demographic, lifestyle, and clinical information has now been expanded to include genetic, cellular, biomarker and metabolomic information from collected biological specimens.

Latest News

Dr. Karen Kopciuk, and colleagues, are recent recipients of a Strategic Clinical Network seed grant

CEPR’s Dr. Karen Kopciuk, together with Dr Huiming Yang and their colleagues, were recently awarded a Strategic Clinical Network (SCN) seed grant entitled:  Test of cure: Use of Human Papillomavirus (HPV) testing to optimize the cervical cancer screening clinical pathway post-treatment.  This grant was one of four grants recently awarded by the SCN for which there was…

Read more

Events

There are no upcoming events.

Follow Us On Twitter

Do You Have Questions?

Send us an email and we will be in touch with you shorty. If you’d like your email directed to one of our Research Scientists, please address the message to them and it will be forwarded.